Again, the dysregulation of CEP55, CLDN4, CHAF1A, H19 and STEAP4 have been found to significantly correlate with CRC tumor stage, aggressiveness, metastasis and poor prognosis [59–63]. The gene discussed is H19; the disease is colorectal carcinoma.